Legumes, known for their high fiber and protein content, offer an economical dietary option but their role in regulating glycemia in type 2 diabetes (T2D) remains underexplored. This narrative review compiles existing studies on how legume consumption impacts gut microbiota and glycemic outcomes. Seventeen studies—three involving humans and fourteen involving animals—were included after a comprehensive search of MEDLINE and the Cochrane Central Register of Controlled Trials.
Read More
Human trials indicate that legume intake correlates with improved glucose tolerance, though the effect on microbiota is inconsistent. In contrast, animal studies show clearer benefits such as enhanced insulin sensitivity and increased microbial diversity when larger amounts of legumes were consumed. Beneficial bacteria like Bifidobacterium and Akkermansia have been found to proliferate with legume consumption. Additionally, the intake of legumes has been associated with higher levels of short-chain fatty acids (SCFAs), which play a crucial role in insulin-related metabolic processes. However, there is still no definitive evidence linking microbiota changes directly to improvements in glycemic control in human subjects.
Type 2 diabetes is marked by chronic high blood sugar levels, often due to insulin resistance. Dietary alterations, particularly those enhancing quality, can positively affect glycemic management. Legumes are recommended by dietary guidelines, including those from the American Diabetes Association, for their insulin-sensitizing properties and ability to improve glycemic control.
Although the microbiome may influence metabolic health through various pathways, the specific mechanisms connecting legume consumption to improved diabetic outcomes are still not entirely understood. Most current reviews have focused on broader dietary patterns rather than the specific effects of legumes.
In synthesis, this review highlights a potential link between legume intake, gut microbiome changes, and glycemic control. It calls for further research to clarify whether these microbial shifts contribute directly to glycemic improvement or if they are simply correlated, emphasizing the need for robust clinical trials with functional microbiome analyses that could illuminate the interrelations in this complex system. A more thorough understanding could reinforce recommendations for legume inclusion in diets aimed at managing T2D.